Micro
Emerging
Active
RARE DTX301 Phase 3 Study Success
Score
0.4
Velocity
▲ 0.0
Articles
1
Sources
1
Summary
An article belongs to this narrative if it discusses the Phase 3 results of Ultragenyx's DTX301 gene therapy.
Timeline
Last Updated
Apr 02, 2026